Related Experiment Video

Updated: May 29, 2026

Stromal Cell Isolation From Hematopoietic Organs
05:27

Stromal Cell Isolation From Hematopoietic Organs

Published on: January 26, 2024

Defining bad stroma in human breast tumors

Anthony Howell

    Cell Cycle (Georgetown, Tex.)
    |September 14, 2011
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
    09:01

    Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

    Published on: July 3, 2025

    Mammosphere Formation Assay from Human Breast Cancer Tissues and Cell Lines
    10:51

    Mammosphere Formation Assay from Human Breast Cancer Tissues and Cell Lines

    Published on: March 22, 2015

    Related Experiment Videos

    Last Updated: May 29, 2026

    Stromal Cell Isolation From Hematopoietic Organs
    05:27

    Stromal Cell Isolation From Hematopoietic Organs

    Published on: January 26, 2024

    Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
    09:01

    Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

    Published on: July 3, 2025

    Mammosphere Formation Assay from Human Breast Cancer Tissues and Cell Lines
    10:51

    Mammosphere Formation Assay from Human Breast Cancer Tissues and Cell Lines

    Published on: March 22, 2015

    Related Concept Videos

    The Tumor Microenvironment02:17

    The Tumor Microenvironment

    Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

    Articles linked to this work by shared authors, journal, and citation graph.

    How do women experience a change in their clinically-derived breast cancer risk estimates: views from a UK family history risk and prevention clinic.

    BMC cancer·2026

    Validation of the pathology-adjusted Manchester scoring system in over 10 000 assessments of cases with breast and/or ovarian cancer.

    Journal of medical genetics·2025

    Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.

    Cancers·2025

    Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer.

    Breast (Edinburgh, Scotland)·2025

    Anti-progestin therapy targets hallmarks of breast cancer risk.

    Nature·2025

    Mammographic density assessed using deep learning in women at high risk of developing breast cancer: the effect of weight change on density.

    Biomedical physics & engineering express·2025

    The effect of energy metabolism on embryonic development and endometrial receptivity in patients with repeated implantation failure.

    Cell cycle (Georgetown, Tex.)·2026

    Integrated multi-level transcriptomic and bioinformatics analysis identifies lipid metabolism-ubiquitination signatures and reveals ATG5, ASB4, LDLR, and CD36 as Candidate biomarkers in insulin resistance.

    Cell cycle (Georgetown, Tex.)·2026

    The role of IL-37 in inflammatory bowel disease and colitis-associated colorectal cancer.

    Cell cycle (Georgetown, Tex.)·2026

    Exploratory multi-omics links CCL2/TIMP1 axis to immunosuppressive TME in glioblastoma.

    Cell cycle (Georgetown, Tex.)·2026

    Circular RNA circ_0001829 attenuates G2/M arrest to promote hepatocyte proliferation by sponging miR-3095-3p following liver injury.

    Cell cycle (Georgetown, Tex.)·2026

    Identification of PGF+ endothelial cells associated with plaque instability in carotid atherosclerosis by scRNA-seq and RNA-seq analysis.

    Cell cycle (Georgetown, Tex.)·2026

    GATA1 knockdown enhances CD8+ T cell responses and protects against immune escape in cervical squamous cell carcinoma through FGL1 downregulation.

    Journal of molecular histology·2026

    Tolerability of [161Tb]Tb-SibuDAB in comparison to other PSMA-targeting radioligands in the preclinical setting.

    European journal of nuclear medicine and molecular imaging·2026

    Efficacy and safety of adjuvant CDK4/6 inhibitors in hormone receptor-positive, HER2-negative early breast cancer: Updated evidence from a systematic review and meta-analysis.

    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

    Decision-to-outcome analysis of multidisciplinary tumor board-managed NSCLC patients.

    Turk gogus kalp damar cerrahisi dergisi·2026

    Electronic Structure Engineering at C7 Position of Thieno-Cytosine (thC): Toward Optimal Probe-Adduct Interactions with ABPG in DNA.

    The journal of physical chemistry. B·2026

    How Functional Variants Reconfigure the Rac2 Conformational Landscape.

    The journal of physical chemistry. B·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us